39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mediouni S, Mou H, Otsuka Y, Jablonski JA, Adcock RS, Batra L, Chung DH, Rood C, de Vera IMS, Rahaim R, Ullah S, Yu X, Getmanenko YA, Kennedy NM, Wang C, ... ... Bannister TD, et al. Identification of potent small molecule inhibitors of SARS-CoV-2 entry. Slas Discovery : Advancing Life Sciences R & D. PMID 35058179 DOI: 10.1016/j.slasd.2021.10.012  0.666
2019 Kim J, Wang C, Ruiz de Sabando A, Cole HL, Huang TJ, Yang J, Bannister TD, Yang VW, Bialkowska AB. The novel small molecule SR18662 efficiently inhibits the growth of colorectal cancer in vitro and in vivo. Molecular Cancer Therapeutics. PMID 31358661 DOI: 10.1158/1535-7163.Mct-18-1366  0.3
2019 Lin H, Pan X, Barsamian AL, Kamenecka TM, Bannister TD. Native Directed Site-Selective δ-C(sp3)–H and δ-C(sp2)–H Arylation of Primary Amines Acs Catalysis. 9: 4887-4891. DOI: 10.1021/Acscatal.8B04927  0.311
2018 Kennedy NM, Schmid CL, Ross NC, Lovell KM, Yue Z, Chen YT, Cameron MD, Bohn LM, Bannister TD. Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias. Journal of Medicinal Chemistry. PMID 30199635 DOI: 10.1021/Acs.Jmedchem.8B01136  0.473
2018 Nieto A, Fernández-Vega V, Spicer TP, Sturchler E, Adhikari P, Kennedy N, Mandat S, Chase P, Scampavia L, Bannister T, Hodder P, McDonald PH. Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. Assay and Drug Development Technologies. 16: 278-288. PMID 30019946 DOI: 10.1089/Adt.2018.849  0.301
2018 Lin H, Wang C, Bannister T, Kamenecka T. Site-selective ɤ-C(sp3)-H and ɤ-C(sp2)-H Arylation of Free Amino Esters Promoted by a Catalytic Transient Directing Group. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29775502 DOI: 10.1002/Chem.201802465  0.324
2016 Madoux F, Dreymuller D, Pettiloud JP, Santos R, Becker-Pauly C, Ludwig A, Fields GB, Bannister T, Spicer TP, Cudic M, Scampavia LD, Minond D. Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate. Scientific Reports. 6: 11. PMID 28442704 DOI: 10.1038/S41598-016-0013-4  0.333
2016 Nair RN, Mishra JK, Li F, Tortosa M, Yang C, Doherty JR, Cameron M, Cleveland JL, Roush WR, Bannister TD. Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors. Medchemcomm. 7: 900-905. PMID 27347360 DOI: 10.1039/C5Md00579E  0.678
2016 Smith E, Janovick JA, Bannister TD, Shumate J, Scampavia L, Conn PM, Spicer TP. Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus. Journal of Biomolecular Screening. PMID 27280550 DOI: 10.1177/1087057116653925  0.315
2016 Pan X, Yang C, Cleveland JL, Bannister TD. Synthesis and Cytoxicity of Sempervirine and Analogues. The Journal of Organic Chemistry. PMID 26828413 DOI: 10.1021/Acs.Joc.6B00022  0.339
2016 Nair RN, Bannister TD. Tale of Two Protecting Groups - Boc vs SEM - For Directed Lithiation and C-C Bond Formation on a Pyrrolopyridazinone Core Organic Process Research and Development. 20: 1370-1376. DOI: 10.1021/Acs.Oprd.6B00128  0.336
2015 Wang H, Wang C, Bannister TD. Preparation of tetrasubstituted pyrimido[4,5-d]pyrimidine diones. Tetrahedron Letters. 56: 1949-4952. PMID 27087706 DOI: 10.1016/J.Tetlet.2015.02.051  0.374
2015 Abdul-Hay SO, Bannister TD, Wang H, Cameron MD, Caulfield TR, Masson A, Bertrand J, Howard EA, McGuire MP, Crisafulli U, Rosenberry TR, Topper CL, Thompson CR, Schürer SC, Madoux F, et al. Selective targeting of extracellular insulin-degrading enzyme by quasi-irreversible thiol-modifying inhibitors. Acs Chemical Biology. PMID 26398879 DOI: 10.1021/Acschembio.5B00334  0.331
2015 Nair RN, Bannister TD. One-pot directed alkylation/deprotection strategy for the synthesis of substituted pyrrole[3,4-d]pyridazinones. European Journal of Organic Chemistry. 2015: 1764-1770. PMID 26257580 DOI: 10.1002/Ejoc.201403491  0.353
2015 Ting PY, Damoiseaux R, Titz B, Bradley KA, Graeber TG, Fernández-Vega V, Bannister TD, Chase P, Nair R, Scampavia L, Hodder P, Spicer TP, Colicelli J. Identification of small molecules that disrupt signaling between ABL and its positive regulator RIN1. Plos One. 10: e0121833. PMID 25811598 DOI: 10.1371/Journal.Pone.0121833  0.349
2015 Pedró-Rosa L, Buckner FS, Ranade RM, Eberhart C, Madoux F, Gillespie JR, Koh CY, Brown S, Lohse J, Verlinde CL, Fan E, Bannister T, Scampavia L, Hol WG, Spicer T, et al. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening. Journal of Biomolecular Screening. 20: 122-30. PMID 25163684 DOI: 10.1177/1087057114548832  0.347
2015 de Sabando AR, Bannister TD, Wang C, He Y, Yang VW, Bialkowska A. Tu1974 Ml264: A Small-Molecule Compound That Inhibits Proliferation of Colorectal Cancer Cells by Selectively Targeting Krüppel-Like Factor 5 (KLF5) Gastroenterology. 148: S-950. DOI: 10.1016/S0016-5085(15)33241-8  0.311
2014 Pan X, Bannister TD. Sequential Sonagashira and Larock indole synthesis reactions in a general strategy to prepare biologically active β-carboline-containing alkaloids. Organic Letters. 16: 6124-7. PMID 25393979 DOI: 10.1021/Ol5029783  0.365
2014 Wang H, Yang C, Doherty JR, Roush WR, Cleveland JL, Bannister TD. Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors. Journal of Medicinal Chemistry. 57: 7317-24. PMID 25068893 DOI: 10.1021/Jm500640X  0.515
2014 Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M, Genau HM, Rounbehler RJ, Lu Y, Dang CV, ... ... Bannister TD, et al. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Research. 74: 908-20. PMID 24285728 DOI: 10.1158/0008-5472.Can-13-2034  0.673
2013 Richard DJ, Lena R, Bannister T, Blake N, Pierceall WE, Carlson NE, Keller CE, Koenig M, He Y, Minond D, Mishra J, Cameron M, Spicer T, Hodder P, Cardone MH. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker. Bioorganic & Medicinal Chemistry. 21: 6642-9. PMID 23993674 DOI: 10.1016/J.Bmc.2013.08.017  0.361
2013 Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M, Bannister TD, Almli L, Stevens JS, Bradley B, Binder EB, Wahlestedt C, Ressler KJ. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Science Translational Medicine. 5: 188ra73. PMID 23740899 DOI: 10.1126/Scitranslmed.3005656  0.445
2013 Chowdhury S, Chen YT, Fang X, Grant W, Pocas J, Cameron MD, Ruiz C, Lin L, Park H, Schröter T, Bannister TD, Lograsso PV, Feng Y. Amino acid derived quinazolines as Rock/PKA inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 1592-9. PMID 23416002 DOI: 10.1016/J.Bmcl.2013.01.109  0.553
2013 Richard DJ, Carlson N, Pierceall W, Lena R, Bannister T, Hodder P, Spicer T, Andreeff M, Opferman J, Koss B, Kung A, Cardone M. Abstract 2466: Characterization and development of on-target Mcl-1 inhibitors; BH3 profiling provides a valuable drug discovery tool. Cancer Research. 73: 2466-2466. DOI: 10.1158/1538-7445.Am2013-2466  0.349
2011 Chowdhury S, Sessions EH, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, Schürer S, LoGrasso P, Bannister TD, Feng Y. Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I). Bioorganic & Medicinal Chemistry Letters. 21: 7107-12. PMID 22004718 DOI: 10.1016/J.Bmcl.2011.09.083  0.359
2011 Bialkowska AB, Crisp M, Bannister T, He Y, Chowdhury S, Schur̈er S, Chase P, Spicer T, Madoux F, Tian C, Hodder P, Zaharevitz D, Yang VW. Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screening Molecular Cancer Therapeutics. 10: 2043-2051. PMID 21885866 DOI: 10.1158/1535-7163.Mct-11-0550  0.323
2011 Fang X, Chen YT, Sessions EH, Chowdhury S, Vojkovsky T, Yin Y, Pocas JR, Grant W, Schröter T, Lin L, Ruiz C, Cameron MD, LoGrasso P, Bannister TD, Feng Y. Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 1844-8. PMID 21349713 DOI: 10.1016/J.Bmcl.2011.01.039  0.52
2011 Chen YT, Vojkovsky T, Fang X, Pocas JR, Grant W, Handy AMW, Schröter T, Lograsso P, Bannister TD, Feng Y. Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors Medchemcomm. 2: 73-75. DOI: 10.1039/C0Md00194E  0.538
2010 Sessions EH, Smolinski M, Wang B, Frackowiak B, Chowdhury S, Yin Y, Chen YT, Ruiz C, Lin L, Pocas J, Schröter T, Cameron MD, LoGrasso P, Feng Y, Bannister TD. The development of benzimidazoles as selective rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 1939-43. PMID 20167489 DOI: 10.1016/J.Bmcl.2010.01.124  0.512
2008 Sessions EH, Yin Y, Bannister TD, Weiser A, Griffin E, Pocas J, Cameron MD, Ruiz C, Lin L, Schürer SC, Schröter T, LoGrasso P, Feng Y. Benzimidazole- and benzoxazole-based inhibitors of Rho kinase. Bioorganic & Medicinal Chemistry Letters. 18: 6390-3. PMID 18996009 DOI: 10.1016/J.Bmcl.2008.10.095  0.363
2008 Chen YT, Bannister TD, Weiser A, Griffin E, Lin L, Ruiz C, Cameron MD, Schürer S, Duckett D, Schröter T, LoGrasso P, Feng Y. Chroman-3-amides as potent Rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 6406-9. PMID 18990570 DOI: 10.1016/J.Bmcl.2008.10.080  0.535
2006 Lin J, Deng H, Jin L, Pandey P, Quinn J, Cantin S, Rynkiewicz MJ, Gorga JC, Bibbins F, Celatka CA, Nagafuji P, Bannister TD, Meyers HV, Babine RE, Hayward NJ, et al. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants. Journal of Medicinal Chemistry. 49: 7781-91. PMID 17181160 DOI: 10.1021/Jm060978S  0.335
2006 Deng H, Bannister TD, Jin L, Babine RE, Quinn J, Nagafuji P, Celatka CA, Lin J, Lazarova TI, Rynkiewicz MJ, Bibbins F, Pandey P, Gorga J, Meyers HV, Abdel-Meguid SS, et al. Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an alpha-ketothiazole arginine. Bioorganic & Medicinal Chemistry Letters. 16: 3049-54. PMID 16524727 DOI: 10.1016/J.Bmcl.2006.02.052  0.309
2002 Scheidt KA, Bannister TD, Tasaka A, Wendt MD, Savall BM, Fegley GJ, Roush WR. Total synthesis of (-)-bafilomycin A(1). Journal of the American Chemical Society. 124: 6981-90. PMID 12059221 DOI: 10.1021/Ja017885E  0.749
2002 Roush WR, Bannister TD, Wendt MD, VanNieuwenhze MS, Gustin DJ, Dilley GJ, Lane GC, Scheidt KA, Smith WJ. An NMR method for assigning relative stereochemistry to beta-hydroxy ketones deriving from aldol reactions of methyl ketones. The Journal of Organic Chemistry. 67: 4284-9. PMID 12054964 DOI: 10.1021/Jo0164148  0.624
2002 Roush WR, Bannister TD, Wendt MD, Jablonowski JA, Scheidt KA. Studies on the synthesis of bafilomycin A(1): stereochemical aspects of the fragment assembly aldol reaction for construction of the C(13)-C25) segment. The Journal of Organic Chemistry. 67: 4275-83. PMID 12054963 DOI: 10.1021/Jo016413F  0.627
1999 Scheidt KA, Tasaka A, Bannister TD, Wendt MD, Roush WR. Total Synthesis of (-)-Bafilomycin A : Application of Diastereoselective Crotylboration and Methyl Ketone Aldol Reactions. Angewandte Chemie (International Ed. in English). 38: 1652-1655. PMID 29710989 DOI: 10.1002/(Sici)1521-3773(19990601)38:11<1652::Aid-Anie1652>3.0.Co;2-K  0.613
1993 Roush WR, Bannister TD, Wendt MD. Concerning the diastereofacial selectivity of aldol reactions of chiral methyl ketone enolates: Evidence for remote chelation in the bafilomycin aldol reaction Tetrahedron Letters. 34: 8387-8390. DOI: 10.1016/S0040-4039(00)61340-0  0.509
1992 Roush WR, Bannister TD. Stereoselective synthesis of the C(13)–C(25) segment of bafilomycin A1 Tetrahedron Letters. 33: 3587-3590. DOI: 10.1016/S0040-4039(00)92509-7  0.475
Show low-probability matches.